GL1X · GenesisL1 explorer

MolNFT v1 · #104073 · protein

Crystal structure of P300 histone acetyltransferase domain in complex with an inhibitor, acetonyl-coenzyme a

4PZT · Histone acetyltransferase P300: “Crystal structure of P300 histone acetyltransferase domain in complex with an inhibitor, acetonyl-coenzyme a”. X-ray diffraction, 1 ligand (SOP), 4 pockets (best druggability 0.71). MolNFT v1 #104073…

PDB
4PZT
Type
protein
Length
334 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase P300
EC
2.3.1.48
UniProt
Q09472
Ligands
SOP
Pockets
4 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase P300 (EC 2.3.1.48)protein33441% helix, 20% strandQ09472

Ligands and binding sites

  • SOP · [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl (3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(2-oxopropyl)thio]ethyl}amino)propyl]amino}butyl dihydrogen diphosphate · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13580.710.8344SOP
22020.600.8133DMS
3600.430.8215empty
4660.320.7514empty

Compared structures

  • 4PZT · Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q09472 · AlphaFold monomer V2.0 prediction for histone acetyltransferase P300 (Q09472) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.